A world-first study has shown that it is possible to determine who is likely to get depression in late-life based on a "genetic score." The longitudinal study of more than 12,000 people over 70 paves ...
With Rebrand and US Launch of Depression Test, NeuroKaire Enters Precision Psychiatry Testing Market
The BrightKaire test converts stem cells to neurons and exposes those neurons to different antidepressants to determine how ...
CBT has long been considered a gold-standard treatment for depression—but does it still hold up? A new review of over 60 recent trials suggests its effects remain strong.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback